BioSenic S.A. announced that it has entered into a securities purchase agreement to issue convertible bonds at a price of ?2,100,000 on June 21, 2024. The bonds will be in the form of unsecured, subordinated, registered bonds. The bonds will not bear any coupon and have a maturity date of five years after issuance, which may be extended by up to a year. The transaction will include participation from new investor, Global Tech Opportunities 15. A first tranche of 30 bonds with an aggregate principal amount of ?300,000 will be subscribed for by GTO 15 in the coming days. The second tranche is contemplated for the 10 July 2024. The issue and subscription of the remaining five tranches, each with a principal amount of ?300,000, can be requested at company?s sole discretion over a eighteen-month period
beginning on the signing date of the subscription agreement.